Excessive Pricing of Pharmaceuticals in the EU: Balancing between Exploitation and Exploitative Abuse
Normally, after the end of the exclusivity period offered by patents, medicines fall in public domain attracting competing companies to launch generic production that would bring down price levels. for different reasons, generic production of off-patented medicines does not always take place, allowi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2020-12-01
|
| Series: | Baltic Journal of European Studies |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/bjes-2020-0023 |